✦ LIBER ✦

Addressing the Chronic Sorrow of Long-Term Spousal Caregivers: A Primer for Counselors

✍ Scribed by Beth N. Rossheim; Charles R. McAdams III

Publisher: American Counseling Association
Year: 2010
Tongue: English
Weight: 90 KB
Volume: 88
Category: Article
ISSN: 1556-6678
DOI: 10.1002/j.1556-6678.2010.tb00048.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prediction of successful outcome in a ra

Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C

✍ Vandelli, Carmen; Renzo, Francesco; Braun, Hans Bertram; Tisminetzky, Sergio; Al 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

To evaluate the efficacy of a 12-month course of recombinant interferon alpha (IFN-␣2b), and to assess predictive factors of successful response to IFN therapy in chronic active hepatitis C (HCV CAH), 242 patients with histologically proven HCV CAH were assigned randomly to two groups, one treated w

The application of a numerical scoring s

The application of a numerical scoring system for evaluating the histological outcome in patients with chronic hepatitis B followed in long term

✍ Gudrun Lindh; Ola Weiland; Hans Glaumann 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

A numerical scoring system was applied and compared with conventional histological classification to assess the histological outcome in 42 patients with chronic hepatitis B followed for 16 to 162 months (mean = 75 months). Four histological categories in the biopsies were assessed and scored: (i) pi

Fentanyl buccal tablet for the treatment

Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain : A long-term, open-label safety study

✍ Sharon M. Weinstein; John Messina; Fang Xie 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views

Variants in interferon-alpha pathway gen

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

✍ Tania Mara Welzel; Timothy R. Morgan; Herbert L. Bonkovsky; Deepa Naishadham; Ru 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

Combination treatment with pegylated-interferon-alpha (PEG IFN-␣) and ribavirin, the current recommended therapy for chronic hepatitis C virus (HCV) infection, results in a sustained virological response (SVR) in only about half of patients. Because genes involved in the interferon-alpha pathway may